Literature DB >> 19826929

An approach to the validation of flow cytometry methods.

Jo Cunliffe1, Nicola Derbyshire, Sue Keeler, Ruth Coldwell.   

Abstract

This publication outlines an approach for the validation of flow cytometry methods used in the analysis of a wide range of biomarkers. It is written as a guidance document for method validation in a GLP environment, and from the viewpoint of the pharmaceutical industry, but its relevance is wide-ranging. The approach to method validation described is intended as a starting point for further discussion, as well as providing reference material to colleagues developing fit-for-purpose flow cytometry methods. Pre-validation steps are discussed as prerequisite assessments to determine method and reagent suitability, and to minimise variables during the full validation process. The guide to method validation takes account of the many flow cytometry assay types in use, and provides guidance on the types of assessments necessary to produce a fit-for-purpose method suitable for use in a regulatory environment.

Mesh:

Substances:

Year:  2009        PMID: 19826929     DOI: 10.1007/s11095-009-9972-5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

1.  Bioanalytical method validation--a revisit with a decade of progress.

Authors:  V P Shah; K K Midha; J W Findlay; H M Hill; J D Hulse; I J McGilveray; G McKay; K J Miller; R N Patnaik; M L Powell; A Tonelli; C T Viswanathan; A Yacobi
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

2.  Establishment of adult peripheral blood lymphocyte subset reference range for an Asian population by single-platform flow cytometry: influence of age, sex, and race and comparison with other published studies.

Authors:  Wee J Chng; Guat B Tan; Ponnudurai Kuperan
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

3.  Fit-for-purpose method development and validation for successful biomarker measurement.

Authors:  Jean W Lee; Viswanath Devanarayan; Yu Chen Barrett; Russell Weiner; John Allinson; Scott Fountain; Stephen Keller; Ira Weinryb; Marie Green; Larry Duan; James A Rogers; Robert Millham; Peter J O'Brien; Jeff Sailstad; Masood Khan; Chad Ray; John A Wagner
Journal:  Pharm Res       Date:  2006-01-12       Impact factor: 4.200

Review 4.  Biomarker method validation in anticancer drug development.

Authors:  J Cummings; T H Ward; A Greystoke; M Ranson; C Dive
Journal:  Br J Pharmacol       Date:  2007-09-17       Impact factor: 8.739

Review 5.  Confirmatory reanalysis of incurred bioanalytical samples.

Authors:  Mario L Rocci; Viswanath Devanarayan; David B Haughey; Paula Jardieu
Journal:  AAPS J       Date:  2007-10-05       Impact factor: 4.009

Review 6.  Validation of bioanalytical methods.

Authors:  H T Karnes; G Shiu; V P Shah
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

7.  Analysis of the immunological cross reactivities of 213 well characterized monoclonal antibodies with specificities against various leucocyte surface antigens of human and 11 animal species.

Authors:  R Brodersen; F Bijlsma; K Gori; K T Jensen; W Chen; J Dominguez; K Haverson; P F Moore; A Saalmüller; D Sachs; W J Slierendrecht; C Stokes; O Vainio; F Zuckermann; B Aasted
Journal:  Vet Immunol Immunopathol       Date:  1998-06-30       Impact factor: 2.046

8.  A multi-rule Shewhart chart for quality control in clinical chemistry.

Authors:  J O Westgard; P L Barry; M R Hunt; T Groth
Journal:  Clin Chem       Date:  1981-03       Impact factor: 8.327

9.  Method validation and measurement of biomarkers in nonclinical and clinical samples in drug development: a conference report.

Authors:  Jean W Lee; Russ S Weiner; Jeff M Sailstad; Ronald R Bowsher; Dean W Knuth; Peter J O'Brien; Jean L Fourcroy; Rakesh Dixit; Lini Pandite; Robert G Pietrusko; Holly D Soares; Valerie Quarmby; Ole L Vesterqvist; David M Potter; James L Witliff; Herbert A Fritche; Timothy O'Leary; Lorah Perlee; Sunil Kadam; John A Wagner
Journal:  Pharm Res       Date:  2005-04-07       Impact factor: 4.200

10.  Differential pattern of human blood neutrophil activation after stimulation with organic dust in vitro and in vivo.

Authors:  Eva Wikström Jonsson; Lena Palmberg
Journal:  J Occup Environ Med       Date:  2007-02       Impact factor: 2.162

View more
  4 in total

Review 1.  Flow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary Immunodeficiencies.

Authors:  Roshini S Abraham; Geraldine Aubert
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

2.  FLT3, a prognostic biomarker for acute myeloid leukemia (AML): Quantitative monitoring with a simple anti-FLT3 interaction and flow cytometric method.

Authors:  Chadarat Ampasavate; Wasimon Jutapakdee; Rungsinee Phongpradist; Singkome Tima; Adisak Tantiworawit; Pimlak Charoenkwan; Dujrudee Chinwong; Songyot Anuchapreeda
Journal:  J Clin Lab Anal       Date:  2019-02-08       Impact factor: 2.352

3.  Development of a Flow Cytometry Assay to Predict Immune Checkpoint Blockade-Related Complications.

Authors:  Hannah-Lou Schilling; Gunther Glehr; Michael Kapinsky; Norbert Ahrens; Paloma Riquelme; Laura Cordero; Florian Bitterer; Hans J Schlitt; Edward K Geissler; Sebastian Haferkamp; James A Hutchinson; Katharina Kronenberg
Journal:  Front Immunol       Date:  2021-11-16       Impact factor: 7.561

4.  Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study.

Authors:  Mathias Streitz; Tewfik Miloud; Michael Kapinsky; Michael R Reed; Robert Magari; Edward K Geissler; James A Hutchinson; Katrin Vogt; Stephan Schlickeiser; Anders Handrup Kverneland; Christian Meisel; Hans-Dieter Volk; Birgit Sawitzki
Journal:  Transplant Res       Date:  2013-10-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.